Central catheter-related Gordonia bronchialis bacteremia in an immunocompromised patient: A case report, and literature review
Mohammed Alnajjar,
Deena Mudawi,
Honar Cherif,
Samar Mahmoud Hashim,
Ahmed Zaqout,
Amina Bougaila,
Farah Imadeldden Jibril,
Shehab Fareed Mohamed
Affiliations
Mohammed Alnajjar
Division of Internal Medicine, Hamad Medical Corporation, Doha, Qatar; Correspondence to: Division of Internal Medicine, Hamad Medical Corporation, 950 Al-Qawafel Street, Alsadd Area, Doha, Qatar.
Deena Mudawi
Division of Hematology, National Center for Cancer Care and Research (NCCCR), Doha, Qatar
Honar Cherif
Division of Hematology, National Center for Cancer Care and Research (NCCCR), Doha, Qatar
Samar Mahmoud Hashim
Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Ahmed Zaqout
Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Amina Bougaila
Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Farah Imadeldden Jibril
Division of Pharmacy, NCCCR, Doha, Qatar
Shehab Fareed Mohamed
Division of Hematology, National Center for Cancer Care and Research (NCCCR), Doha, Qatar
Gordonia is a rarely reported organism causing central line-associated bloodstream infection (CLABSI). This article reports an acute myeloid leukemia (AML) case in which the patient developed febrile neutropenia and was later found to have Gordonia bronchialis (G. bronchialis) CLABSI. The patient received a two-week ceftriaxone regimen, based on susceptibility. The microbiologic diagnosis of this organism is considered challenging due to its resemblance with other organisms; however, more sophisticated methods of diagnosis (such as gene sequencing) can aid in differentiation.
